A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Name: A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
Published: 2010
License: Public Domain

Merck Sharp & Dohme LLC · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

colorectal-cancer ovarian-cancer

neoplasms malignant, colorectal cancer, solid tumors, ovarian cancer, fallopian tube cancer, primary peritoneal cancer, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Related documents